H. H. Parving, B. M. Brenner, J. J. McMurray, D. de Zeeuw, S. M. Haffner, S. D. Solomon, N. Chaturvedi, M. Ghadanfar, N. Weissbach, Z. Xiang and J. Armbrecht, “Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes,” The New England Journal of Medicine, Vol. 367, 2012, pp. 2204-2213. doi:10.1056/NEJMoa1208799

has been cited by the following article:

• TITLE: Antihypertensive Therapy in Non-Diabetic Chronic Kidney Disease Associated with Proteinuria in Adults

  AUTHORS: Khawar Maqsood, Adeel Siddiqui, Geoffrey Teehan

  KEYWORDS: Hypertension; Proteinuria; Chronic Kidney Disease

  JOURNAL NAME: Open Journal of Nephrology, Vol.3 No.3, September 9, 2013

  ABSTRACT: Controlling blood pressure and reducing proteinuria are common goals in Chronic Kidney Disease associated with hypertension and proteinuria and lead to fewer cardiovascular outcomes. This review summarizes the available literature.